Trichomonas Infection: Remedying Diagnostic Blind Spots

Trichomoniasis is a common sexually transmitted infection affecting mainly women of reproductive age and is caused by the protozoan Trichomonas vaginalis. More than half of infected women present with vaginal discharge, while approximately 10% of infected men develop urethritis or urethral discharge. Despite its high prevalence, the epidemiology of trichomoniasis remains incompletely understood because routine screening is limited and the infection is not consistently monitored.

The disease is both treatable and curable when diagnosed early. Diagnosis can be achieved through clinical assessment as well as several laboratory methods. Conventional laboratory diagnosis includes microscopic examination of saline wet mounts of vaginal or urethral specimens to identify motile trophozoites. Culture techniques, such as Diamond’s medium, offer greater sensitivity than wet mount microscopy but require more time. In recent years, antigen detection assays and nucleic acid amplification tests (NAATs) have become increasingly preferred because of their high sensitivity and specificity, particularly in asymptomatic individuals.

Among these, NAAT is considered the gold standard for diagnosis and is playing an important role in improving sexually transmitted infection control programs. As diagnostic technologies continue to advance, trichomonas testing is expected to become more accurate, accessible, and widely utilized in clinical practice.

Despite the limitations associated with each diagnostic method for detecting Trichomoniasis, efforts should be made to overcome these diagnostic blind spots in order to achieve more accurate and reliable detection of infection.